Champlin R - Search Results

1

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.

Shah N, Li L, McCarty J, Kaur I, Yvon E, Shaim H, Muftuoglu M, Liu E, Orlowski RZ, Cooper L, Lee D, Parmar S, Cao K, Sobieiski C, Saliba R, Hosing C, Ahmed S, Nieto Y, Bashir Q, Patel K, Bollard C, Qazilbash M, Champlin R, Rezvani K, Shpall EJ. Shah N, et al. Among authors: champlin r. Br J Haematol. 2017 May;177(3):457-466. doi: 10.1111/bjh.14570. Epub 2017 Mar 14. Br J Haematol. 2017. PMID: 28295190 Free PMC article. Clinical Trial.

2

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.

Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S. Lee M, et al. Among authors: champlin r. Br J Haematol. 1992 Dec;82(4):708-14. doi: 10.1111/j.1365-2141.1992.tb06948.x. Br J Haematol. 1992. PMID: 1482658

3

Limited value of myeloablative therapy for late multiple myeloma.

Alexanian R, Dimopoulos M, Smith T, Delasalle K, Barlogie B, Champlin R. Alexanian R, et al. Among authors: champlin r. Blood. 1994 Jan 15;83(2):512-6. Blood. 1994. PMID: 7904486 Free article.

4

Intensive sequential therapy for VAD-resistant multiple myeloma.

Dimopoulos MA, Weber DM, Hester J, Delasalle K, Champlin R, Alexanian R. Dimopoulos MA, et al. Among authors: champlin r. Leuk Lymphoma. 1994 May;13(5-6):479-84. doi: 10.3109/10428199409049638. Leuk Lymphoma. 1994. PMID: 7915163 Clinical Trial.

5

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB. Kantarjian HM, et al. Among authors: champlin r. Bone Marrow Transplant. 1994 Jul;14(1):57-61. Bone Marrow Transplant. 1994. PMID: 7951120 Clinical Trial.

6

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.

Dimopoulos MA, Hester J, Huh Y, Champlin R, Alexanian R. Dimopoulos MA, et al. Among authors: champlin r. Br J Haematol. 1994 Aug;87(4):730-4. doi: 10.1111/j.1365-2141.1994.tb06731.x. Br J Haematol. 1994. PMID: 7986714 Clinical Trial.

7

Early myeloablative therapy for multiple myeloma.

Alexanian R, Dimopoulos MA, Hester J, Delasalle K, Champlin R. Alexanian R, et al. Among authors: champlin r. Blood. 1994 Dec 15;84(12):4278-82. Blood. 1994. PMID: 7994043 Free article.

8

Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.

Dimopoulos MA, Delasalle KB, Champlin R, Alexanian R. Dimopoulos MA, et al. Among authors: champlin r. Br J Haematol. 1993 Feb;83(2):240-4. doi: 10.1111/j.1365-2141.1993.tb08278.x. Br J Haematol. 1993. PMID: 8457473 Clinical Trial.

9

Myeloablative therapy for primary resistant multiple myeloma.

Alexanian R, Dimopoulos MA, Delasalle KB, Hester J, Champlin R. Alexanian R, et al. Among authors: champlin r. Stem Cells. 1995 Aug;13 Suppl 2:118-21. doi: 10.1002/stem.5530130718. Stem Cells. 1995. PMID: 8520499 Clinical Trial.

10

Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation.

Anderlini P, Przepiorka D, Huh Y, Lauppe J, Miller P, Sundberg J, Seong D, Champlin R, Körbling M. Anderlini P, et al. Among authors: champlin r. Br J Haematol. 1996 Jun;93(4):940-2. doi: 10.1046/j.1365-2141.1996.d01-1747.x. Br J Haematol. 1996. PMID: 8703830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,166 results

Search Page